Suzhou Basecare Medical Corp. Ltd. Class H ( (HK:2170) ) just unveiled an announcement.
Suzhou Basecare Medical Corporation Limited has received approval from the Jiangsu Medical Products Administration for its portable sperm quality analyzer, a device designed for home use to assess male fertility. This approval marks a significant step in the company’s expansion from professional medical institutions to general consumer applications, potentially broadening its market reach and enhancing its industry positioning.
More about Suzhou Basecare Medical Corp. Ltd. Class H
Suzhou Basecare Medical Corporation Limited is a company based in China that operates in the medical industry. It focuses on developing consumer-oriented medical devices, particularly in the area of male reproductive health.
YTD Price Performance: 4.01%
Average Trading Volume: 160,538
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$981M
Find detailed analytics on 2170 stock on TipRanks’ Stock Analysis page.